Craft

Avrobio

Stock Price

$1.4

2024-06-21

Market Capitalization

$5.2 M

2024-06-21

Avrobio Summary

Company Summary

Overview
Gene therapy has the potential to deliver dramatic disease modifying effects and potentially life-long cures from a single infusion of genetically-modified cells.
Type
Public
Status
Active
HQ
Cambridge, MA, US | view all locations
Website
http://www.avrobio.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Geoff MacKay

    Geoff MacKay, President, CEO and Director

  • Erik Ostrowski

    Erik Ostrowski, Chief Financial Officer

  • Azadeh Golipour

    Azadeh Golipour, Chief Technology Officer

  • Deanna Petersen

    Deanna Petersen, Chief Business Officer

LocationsView all

1 location detected

  • Cambridge, MA HQ

    United States

    One Kendall Square Building 300 Suite 201

Avrobio Financials

Summary Financials

Net income (Q1, 2025)
($15.9M)
Cash (Q1, 2025)
$306.2M
EBIT (Q1, 2025)
($18.3M)
Enterprise value
($298.8M)

Footer menu